Medicus Pharma Ltd. (MDCX)

Medicus Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	8.71	4.16	1.72	0.27
Cash & Short-Term Investments	8.71	4.16	1.72	0.27
Cash Growth	109.04%	142.21%	542.38%	-
Other Current Assets	1.19	1.21	0.17	0.02
Total Current Assets	9.89	5.38	1.89	0.28
Net Property, Plant & Equipment	0.17	0.27	-	-
Total Assets	10.06	5.65	1.89	0.28
Accounts Payable	3.55	1.43	0.38	0.1
Accrued Expenses	1	0.76	0.4	-
Short-Term Debt	5.25	-	-	1.53
Current Portion of Leases	0.15	0.12	-	-
Other Current Liabilities	-	-	-	10.85
Total Current Liabilities	9.94	2.31	0.78	12.48
Long-Term Debt	0.03	-	-	-
Long-Term Leases	0.06	0.21	-	-
Total Long-Term Liabilities	0.09	0.21	-	-
Total Liabilities	10.02	2.51	0.78	12.48
Common Stock	57.08	30.52	18.76	0.19
Additional Paid-in Capital	7.19	1.52	0.1	-
Accumulated Other Comprehensive Income	0.01	-	-	-
Retained Earnings	-64.35	-28.9	-17.75	-12.39
Total Common Shareholders' Equity	-0.07	3.13	1.11	-12.2
Minority Interest	0.1	-	-	-
Shareholders' Equity	0.04	3.13	1.11	-12.2
Total Liabilities & Equity	10.06	5.65	1.89	0.28
Total Debt	5.48	0.32	0	1.53
Net Cash (Debt)	3.23	3.84	1.72	-1.26
Net Cash Growth	-15.98%	123.46%	-	-
Net Cash Per Share	0.19	0.40	0.25	-0.67
Book Value	-0.07	3.13	1.11	-12.2
Book Value Per Share	-0.00	0.33	0.16	-6.47
Tangible Book Value	-0.07	3.13	1.11	-12.2
Tangible Book Value Per Share	-0.00	0.33	0.16	-6.47

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q